cebp.aacrjournals.org/conte...
Background: The association of obesity at diagnosis with prostate cancer progression is uncertain. This study aimed to examine the relationship between body mass index (BMI; 18.5-<25, 25-<30, 30-<35, ≥35kg/m2) and prognostic risk at diagnosis, compare the concordance between prognostic risk assessed at diagnostic biopsy versus pathologic risk assessed at surgery across BMI categories...
Hormone therapy for post prostatectomy cancer recurrence.
Antidepressant medication use and prostate cancer recurrence in men with depressive disorders. 
The accuracy of patients’ perceptions of the risks associated with localised prostate cancer treatments
Unsure of best option in early prostate cancer diagnosis.
Statin Drugs and Prostate Cancer recurrence
